Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1642-1649

  Weyand, Cornelia M ^a,b   Wagner, Annette D ^a   Björnsson, Johannes ^b   Goronzy, Jörg J ^a  

^a Division of Rheumatology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

macrophage differentiation; metalloproteinase; TGF 1; vasculitis

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MACROPHAGE; PRIORITY JOURNAL;

EID: 0029797606     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118959     Document Type: Article

References (27)

1. Cid, M.C., E. Campo, G. Ercilla, A. Palacin, J. Vilaseca, J. Villalta, and M. Ingelmo. 1989. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum. 32:884-893.
2. Weyand, C.M., J. Schönherger, U. Oppitz, N.N.H. Hunder, K.C. Hicok, and J.J. Goronzy. 1994. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J. Exp. Med. 179:951-960.
3. + cells in giant cell arteritis. Evidence for two components of the disease. J. Clin. Invest. 94:1134-1140.
4. Roche, N.E., J.W. Fulbright, A.D. Wagner, G.G. Hunder, J.J. Goronzy, and C.M. Weyand. 1993. Correlation of interleukin 6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 36: 1286-1294.
5. Wagner, A.D., J. Björnsson, G.B. Hartley, J.J. Goronzy, and C.M. Weyand. 1996. Interferon gamma producing T cells in giant cell vasculitis represent a minority of tissue infiltrating cells and are located distant from the site of pathology. Am. J. Pathol. 148:1925-1933.
6. Hunder, G.G., D.A. Bloch, B.A. Michel, M.B. Stevens, W.P. Arend, L.H. Calabrese, S.M. Edworthy, A.S. Fauci, R.Y. Leavitt, J.T. Lie, R.W. Lightfoot. Jr., A.T. Masi, D.J. McShane, J.A. Mills, S.L. Wallace, and N.J. Zvaifler. 1990. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 33:1122-1128.
7. Weyand, C.M., K.C. Hicok, G.G. Hunder, and J.J. Goronzy. 1994. Tissue cytokine patterns in polymyalgia rheumatica and giant cell arteritis. Ann. Inlern. Med. 121:484-191.
8. Weyand, C.M., and J.J. Goronzy. 1995. Giant cell arteritis as an antigen driven disease. Rheum. Dis. Clin. N. Am. 21:1027-1039.
9. Doherty, T.M. 1995. T-cell regulation of macrophage function. Curr. Opin. Immunol. 7:400-404.
10. Chuang, T.Y., G.G. Hunder, D.M. Ilstrup, and L.T. Kurland. 1982. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann. Intern. Med. 97:672-680.
11. Weyand, C.M., N. Tetzlaff, J. Björnsson, and J.J. Goronzy. Disease patterns and tissue cylokine profiles in giant cell arteritis. Arthritis Rheum. In press.
12. Minami, Y., T. Kono, T. Miyazaki, and T. Taniguchi. 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11:245-268.
13. Kupfer, A., S.L. Swain, and S.J. Singer. 1987. The specific direct interaction of helper T cells and antigen presenting B cells. II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the hound helper T cells. J. Exp. Med. 165:1565-1580.
14. Wahl, S.M. 1994. Transforming growth factor beta: the good, the bad. and the ugly. J. Exp. Med. 180:1587-1590.
15. Lowrance, J.H., F.X. O'Sullivan, T.E. Caver, W. Waegell, and H.D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
16. Barral-Netto, M., A. Barral, C.E. Brownell, Y.A. Skeiky, L.R. Ellingsworth. D.R. Twardzik, and S.G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science (Wash. DC). 257: 545-548.
17. Allen, J.B., C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworth, and S.M. Wahl. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J. Exp. Med. 171:231-247.
18. Wahl, S.M., J.B. Allen, G.I., Costa, H.L. Wong, and J.R. Dasch. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J. Exp. Med. 177:225-230.
19. Sporn, M.B., and A.B. Roberts. 1990. The transforming growth factor-βs. In Peptide Growth Factors and Their Receptors. I. M.B. Sporn, and A.B. Roberts, editors. Springer-Verlag, New York. 419 pp.
20. Wahl, S.M., D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, A.B. Roberts, and M.B. Sporn. 1987. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:5788-5792.
21. Wahl, S.M., J.B. Allen, B.S. Weeks, H.L. Wong, and P.E. Klotman. 1993. TGF-β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:4577-4581.
22. Roberts, A.R., B.K. McCune, and M.B. Sporn. 1992. TGF-beta: regulation of extracellular matrix. Kidney Int. 41:557-559.
23. Dusting, G.J. 1995. Nitric oxide in cardiovascular disorders. J. Vasc. Res. 32:143-161.
24. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
25. Clancy, R.M., and S.B. Abramson. 1995. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210:93-101.
26. Vodovotz, Y., C. Bogdan, J. Paik, Q.-W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med. 178:605-613.
27. Merryman, P.F., R.M. Clancy, X.Y. He, and S.B. Abramson. 1993. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglulathione. Arthritis Rheum. 36:1414-1422.